
Thyme Care Banks $97M to Accelerate Value-Based Cancer Care
Thyme Care's Series D round included participation from CVS Health Ventures, Foresite Capital, Morgan Health and Humana. In total, it has raised $275 million.
Thyme Care's Series D round included participation from CVS Health Ventures, Foresite Capital, Morgan Health and Humana. In total, it has raised $275 million.
Seven Starling's $8 million raise was led by Rethink Impact and included participation from Pear VC, Zeal Capital Partners, Magnify Ventures, Ulu Ventures, Expa, Fiore Ventures, the March of Dimes, Rogue Women's Fund and Graham & Walker.
Harbor Health's funding was co-led by General Catalyst, 8VC and Alta Partners. The round also includes participation from Dell Family Office Management, Health 2047 Capital Partners, Lemhi Ventures, Martin Ventures and Breyer Capital.
Goodpath’s Series A round was led by MassMutual Ventures and included participation from Healthy Ventures. In total, the company has raised $22 million.
Strive Health's Series D funding was led by New Enterprise Associates, and included participation from CVS Health Ventures, CapitalG, Echo Health and several others.
Hello Patient's Series A round was led by Scale Venture Partners and included participation from 8VC, Bling Capital, Max Ventures, Remus Capital and FirstLook Partners.
Sleep.ai’s $5.5 million in funding was led by Treasure Coast Ventures and included participation from Nurture Ventures, the Harvard Business School Alumni Angels of Greater New York and Supermoon Capital.
Develop Health's Series A funding round was led by Wing Venture Capital, and included participation from Afore Capital, J Ventures and South Park Commons.
Arbital Health’s $31 million Series B round was led by Valtruis and included participation from existing investors Transformation Capital, Shaper Capital and Healthy Ventures.
Certify's $40 million round was led by Transformation Capital, and included support from General Catalyst, Upfront Ventures and SemperVirens.
WellTheory's $5 million raise included support from new investors Samsung Next, Opal Ventures and Up2 Fund, as well as existing investors Accel, OVO Fund and BoxGroup.
As the safety-net landscape shifts and funding uncertainty grows, the path forward is clear. By investing in highly coordinated, data-informed care and aligning health plans, providers and communities around shared goals, we can build a system that reaches individuals with complex care needs, supports whole-person health initiatives and strengthens care across the board.
A webinar scheduled for Thursday May 8 at 1 pm ET sponsored by Mercury will explore how early-stage medtech and biopharma investors are looking at the market and how they're advising startups in the wake of cuts to NIH and SBIR grants.
GEM HEALTH's Series A round was co-led by HealthTrend Capital and LFE Capital and included participation from existing investors Base10 Partners and Mairs & Power Venture Capital.
This year, venture capitalists in the digital health landscape have many more quality investment opportunities than they did in the past couple years, according to Oak HC/FT Partner Billy Deitch. He noted that many startups have been preserving the capital over the past two years with the plan to raise funds in 2025.